Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Finch Therapeutics Group, Inc. (FNCH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Blischak Matthew P. (CEO) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 962,899 options to buy
@ $0.285, valued at
$274.4k
|
|
| 06/09/2023 |
4
| Lange Christian H. (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 06/09/2023 |
4
| SMISEK JEFFERY A (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 06/09/2023 |
4
| Haft Nicholas (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 06/09/2023 |
4
| FERRANTE DOMENIC J (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 06/09/2023 |
4
| Graf Susan E (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Bought 5,010 shares
@ $0.27, valued at
$1.4k
Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 06/09/2023 |
4
| Shumway Chris (10% Owner) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 02/23/2023 |
4
| Blaustein Marc (COO) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Sold 4,619 shares
@ $0.38, valued at
$1.8k
|
|
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Shumway Chris (10% Owner) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 44,843 options to buy
@ $2.79, valued at
$125.1k
|
|
| 06/15/2022 |
4
| Lange Christian H. (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 44,843 options to buy
@ $2.79, valued at
$125.1k
|
|
| 06/15/2022 |
4
| Blaustein Marc (COO) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Haft Nicholas (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 44,843 options to buy
@ $2.79, valued at
$125.1k
|
|
| 02/28/2022 |
4
| Blaustein Marc (COO) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 38,000 options to buy
@ $8.61, valued at
$327.2k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2021 |
4
| Haft Nicholas (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Bought 63,850 shares
@ $10.18, valued at
$650k
|
|
| 12/21/2021 |
4
| Vittiglio Joseph (Chief Business & Legal Officer) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 125,000 options to buy
@ $9.68, valued at
$1.2M
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Blaustein Marc (COO) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 150,000 options to buy
@ $15.56, valued at
$2.3M
|
|
| 05/14/2021 |
4
| Viney Joanne L. (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 23,419 options to buy
@ $12.27, valued at
$287.4k
|
|
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Haft Nicholas (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Converted 172,942 shares
@ $0
Converted 143,831 shares
@ $0
Converted 1,064,466 shares
@ $0
Converted 366,093 shares
@ $0
Converted 212,893 shares
@ $0
Converted 1,150,481 shares
@ $0
Bought 882,351 shares
@ $17, valued at
$15M
Converted 172,942 preferred shares
@ $0
Converted 143,831 preferred shares
@ $0
Converted 1,064,466 preferred shares
@ $0
Converted 366,093 preferred shares
@ $0 |
|
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Crestovo Investor LLC (10% Owner) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Converted 11,906,147 shares
@ $0
Bought 735,294 shares
@ $17, valued at
$12.5M
Converted 8,672,117 preferred shares
@ $0
Converted 1,064,466 preferred shares
@ $0
Converted 1,172,480 preferred shares
@ $0
Converted 997,084 preferred shares
@ $0 |
|
| 03/18/2021 |
4
| Vittiglio Joseph (General Counsel and Secretary) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 34,616 options to buy
@ $17, valued at
$588.5k
Granted 60,578 options to buy
@ $17, valued at
$1M
|
|
|
|
|